Cancer Research UK and MedImmune launch biotherapeutics research centre
14 September 2015 | By Victoria White
The new laboratory, opened in Cambridge, will focus on the discovery and development of novel biologic cancer treatments and diagnostics...
List view / Grid view
News
Researchers discover new group of antibiotics
14 September 2015 | By Victoria White
The potential new antibiotics are unlike contemporary antibiotics because they contain iridium, a silvery-white transition metal...
Takeda joins malaria and TB drug discovery consortium, WIPO Re:Search
14 September 2015 | By Victoria White
WIPO Re:Search provides access to the intellectual property of certain pharmaceutical compounds, technologies, know-how and data for R&D activities around TB and malaria...
Researchers develop a new computational method to study cancer drug effects
11 September 2015 | By Victoria White
Researchers have developed a new method for studying the targets and effects of cancer drugs using data from discovery mass spectrometry experiments...
New technique improves the selectivity of kinase inhibitors
11 September 2015 | By Victoria White
The new technique could cut the potential for side effects and help usher kinase inhibitors past strict regulatory hurdles...
Scientists discover why levodopa can lead to dyskinesia
11 September 2015 | By Victoria White
Researchers have discovered why long-term use of levodopa, a treatment for Parkinson's disease, commonly leads to a movement problem called dyskinesia...
Technology for large-scale protein manufacture unveiled
11 September 2015 | By Victoria White
Researchers have developed the user-friendly technology to help scientists understand how proteins work and fix them when they are broken...
Gencia and Takeda to develop novel mitochondrial therapeutics
11 September 2015 | By Victoria White
Gencia and Takeda aim to jointly research and develop two preclinical drug candidates, one each in the areas of inflammation and oncology...
SAS1B discovery could fundamentally alter cancer treatment
10 September 2015 | By Victoria White
The SAS1B protein appears only on egg cells and cancer cells, and could serve as a target for tiny tracking probes created using monoclonal antibodies...
MGB Biopharma wins Scottish Business Award
10 September 2015 | By Victoria White
MGB Biopharma was one of three shortlisted finalists for the “Early Stage/ Risk Capital Deal of the Year” category which is awarded for a deal made by an early stage company...
Blueprint Medicines to advance BLU-285 in Phase 1 trial for systemic mastocytosis
10 September 2015 | By Victoria White
BLU-285 is a potent and highly selective inhibitor of the KIT D816V mutant, the primary driver of disease in more than 94% of systemic mastocytosis patients...
Pretreated monocytes may confer positive effects for Alzheimer’s sufferers
10 September 2015 | By Victoria White
Administration of human umbilical cord blood cell-derived monocytes diminished Aβ pathology in test models and also improved hippocampal-dependent learning, memory and motor function...
Scientists make biodegradable pharmaceuticals
9 September 2015 | By Victoria White
Scientists from Leuphana University Lüneburg have developed a way to make drugs that break down into harmless compounds before they contaminate our water supply...
TxCell announces preclinical efficacy results for Col-Treg in autoimmune uveitis
9 September 2015 | By Victoria White
In vivo administration of Col-Treg in the model of autoimmune uveitis significantly inhibited clinical symptoms, retinal tissue lesions as well as ocular proinflammatory cell infiltration...
Testicular cancer found to be ‘strongly heritable’
9 September 2015 | By Victoria White
New research suggests genetic inheritance is much more important in testicular cancer than in most other cancer types, where genetics typically accounts for less than 20% of risk...
